cell-based diagnostics Stanford Spinout Levitas Bio to Launch Magnetic Levitation Cell Separation Platform Premium The Bay Area startup is offering a no-touch method to separate cell populations for downstream analysis in genomics and synthetic biology applications. Biolidics, A*STAR Genome Institute of Singapore to Develop Liquid Biopsy Breast Cancer Test The company will work with the Genome Institute of Singapore to create a test for breast cancer recurrence prediction using its circulating tumor cell platform. Clearbridge Signs China Distribution, Test Development Deal with Agen Lab The company will supply the Chinese laboratory with its ClearCell FX1 system and help train and assist its new partner in developing cancer tests. Singapore's Clearbridge Biomedics Secures S$6.6M in Funding Ahead of Planned IPO The financing will support business expansion, continued technology development, and expenses related to a planned listing at the end of the year. Amarantus Reacquires Neurology Diagnostic Assets from Avant Amarantus has reacquired LymPro Test, MSPrecise, and NuroPro and said that it plans to assign the assets to a new subsidiary. Apr 14, 2015 Novacyt Raises $2.3M to Support Launch of Cytology Platform in China Jun 18, 2014 Fluxion, Stanford Team on CTC Test Development Aug 21, 2013 With Prospective Data, Precision Therapeutics Hoping to Ramp up ChemoFx Adoption, Reimbursement Premium Jul 9, 2013 MBio Achieves ISO 13485:2003 Certification Feb 12, 2013 Swiss Organizations Partner to Improve Flow Cytometry Data Analysis Jan 29, 2013 Oxford Immunotec, Lophius Ink Licensing Deals for Development of T-cell-based Assays Dec 13, 2012 China Approves Veridex's CellSearch Test for Metastatic Breast Cancer Sep 12, 2012 IncellDx Partners with BRL on Trial of OncoTect 3Dx Aug 6, 2012 Wayne State Lands Grant for Fetal Dx Jul 9, 2012 BioView, ScreenCell Partner to Develop CTC Analysis Technology Jun 26, 2012 Stratos, nanoMR Co-developing Instrument for Pathogen Detection May 21, 2012 Atossa Genetics Discloses Net Losses of $3.4M in FY 2011, $1.1M in Q1 2012 May 15, 2012 Accelr8, Denver Health Get $2M Grant for Infections Dx Project Apr 30, 2012 Bio-Reference Labs Investing up to $6M in InCellDx Apr 18, 2012 LeukoDx Closes $1.6M Financing Tranche, Inks Agreements for up to $8M Oct 19, 2011 VisionGate Raises $2M, Partners on Technology for Lung Cancer Testing Oct 13, 2011 Novartis Deal to Evaluate Accelr8's BACcel Platform Expires Without Further Extension Sep 16, 2011 NIH, FDA, DARPA to Fund Development of Chip for Drug Safety Assessment Aug 24, 2011 Startup OncoCyte to Use $10M Equity Infusion to Develop Cancer Dx, Therapeutics Aug 23, 2011 Cancer Dx Firm BioMarker Strategies Raises $1.1M of Targeted $4M Round Load More Breaking News BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M Thermo Fisher Scientific Next-Generation SARS-CoV-2 PCR Test Nabs CE-IVD Mark Cytosine Base Editor Enables Genome-Wide Genetic Function Screening The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.